Skip to main content

Adjuvant Chemotherapy of Testicular Carcinoma: Need for Evaluation of Curative Strategies

  • Chapter
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 68))

  • 66 Accesses

Abstract

Newer regimens including cis-diamminedichloroplatinum (DDP) have shown a striking therapeutic efficacy against advanced testicular cancer [22]. The impact of such chemotherapy on our overall approach to this disease will be described. Preceding the description of current trials, a review of staging concepts and the prognostic implications of histology and stage is essential to understanding the concepts underlying current strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. American Joint Committee for Cancer Staging and End Results Reporting. 1977.

    Google Scholar 

  2. Anderson, T., Waiden, T., Javadpour, N., Anderson, T., Glatstein, E.: Recent advances in diagnosis and therapy of testicular germ cell neoplasms. Ann. Intern. Med. (in press) (1978).

    Google Scholar 

  3. Boden, G. L., Gibb, R.: Radiotherapy and testicular neoplasms. Lancet 1951 II, 1195.

    Google Scholar 

  4. Carter, S. K., Wasserman, T. H.: The chemotherapy of urologic cancer. Cancer 36, 729–749 (1975).

    Article  PubMed  CAS  Google Scholar 

  5. Chary, K., Higby, D., Henderson, E., Swinerton, K.: Phase I study of high dose cis-diamminedichloroplatinum(II) with forced diuresis. Cancer Treat. Rep. 61, 367–370 (1977).

    PubMed  CAS  Google Scholar 

  6. Cheng, E., Cvitkovic, E., Wittes, R., Golbey, R.: Germ cel tumors (II): VAB II in metastatic testicular cancer. Cancer (in press) (1978).

    Google Scholar 

  7. Collins, D. H., Pugh, R. C. B.: Classification and frequency of testicular tumors. Br. J. Urol. 36, [Suppl 1], 1, (1964).

    Google Scholar 

  8. Corder, M. P., Maguire, L. C., Witte, D. L., Panther, S. K., Lovett, J. M., Dietz, B. J.: Weekly outpatient cis-platinum(II) diamminedichloride (CPDD) and diuresis with dose-limiting myelosuppression. Proc. Am. Assoc. Cancer Res./Proc. Am. Soc. Clin. Oncol. 18, 344 (1977).

    Google Scholar 

  9. Cvitkovic, E., Hayes, D., Golbey, R.: Primary combination chemotherapy (VAB III) for metastatic or unresectable germ cell tumors. Proc. Am. Assoc. Cancer Res. 17, 296 (1976) (Abs.).

    Google Scholar 

  10. Dixon, F., Moore, R.: Tumors of the male sex organs. In: Atlas of tumor pathology. Section 8, Part 31b and 32, pp. 48-127. Washington D. C.: Armed Forces Institute of Pathology.

    Google Scholar 

  11. Einhorn, L. H., Donohue, J. P.: Cis-diammine-dichloroplatinum, vinblastine, and bleomycin combination chemotherapy in dissemminated testicular cancer. Ann. Intern. Med. 87, 293–298 (1977).

    PubMed  CAS  Google Scholar 

  12. Hayes, D. M., Cvitkovic, E., Golbey, R. B., Scheiner, E., Helson, L., Krakoff, I. H.: High dose cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39, 1372–1381 (1977).

    Article  PubMed  CAS  Google Scholar 

  13. Higby, D. J., Wallace, H. J., Albert, D., Holland, J. F.: Diamminodichloroplatinum in the chemotherapy of testicular tumors. J. Urol. 112, 100–104 (1974).

    PubMed  CAS  Google Scholar 

  14. Hussey, D. H., Luk, K. H., Johnson, D. E.: The role of radiation therapy in the treatment of germinal cell tumors of the testis other than pure seminoma. Radiology 123, 175–180 (1977).

    PubMed  CAS  Google Scholar 

  15. Javadpour, N., Bergman, S.: Recent advances in testicular cancer. Curr. Probl. Surg. 25, 1–64 (1978).

    Article  Google Scholar 

  16. Lynch, D. F., McCord, L., Nicholson, T., Richie, J., Sargents, C.: Sandwich therapy in testis tumor: current experience. J. Urol. 119, 612–613 (1977).

    Google Scholar 

  17. Maier, J. G., VanBuskirk, K. E.: Treatment of testicular germ cell malignancies. JAMA 213, 97–98 (1970).

    Article  PubMed  CAS  Google Scholar 

  18. Maier, J. G., Mittemeyer, B. T.: Carcinoma of the testis. Cancer 39, 981–986 (1977).

    Article  PubMed  CAS  Google Scholar 

  19. Merrin, C.: A new method to prevent toxicity with high doses of cisdiammine platinum (therapeutic efficacy in previously treated widespread and recurrent testicular tumors). Proc. Am. Assoc. Cancer Res./Proc. Am. Soc. Clin. Oncol. 17, 243 (1976).

    Google Scholar 

  20. Merrin, C.: Multimodal treatment of advanced testicular tumor with cis-diammine dichloroplatinum (CPDD), bleomycin (BLEO), vinblastine (VLB), vincristine (VCR) and actinomycin D. Proc. Am. Assoc. Cancer Res. 18, 298 (1977).

    Google Scholar 

  21. Mostofi, F.: Testicular tumors: epidemiologic, etiologic, and pathologic features. Cancer 32, 1186–1201 (1973).

    Article  PubMed  CAS  Google Scholar 

  22. Muggia, F. M., Jacobs, E. M.: Chemotherapy of testicular cancer: Impact on curability. Princess Takamatsu Symposium (in press) (1978).

    Google Scholar 

  23. Nitschke, R., Starling, K., Land, V., Komp, D.: Cis-platinum (PDD) in childhood malignancies. Proc. Am. Assoc. Cancer Res. 17, 310 (1976).

    Google Scholar 

  24. Osieka, R., Bruntsch, U., Gallmeier, W., Seeber, S., Schmidt, C.: Cis-diamminodichloro-platin in der Behandlung therapieresistenter maligner Hodenteratome. Dtsch. Med. Wochenschr. 101, 191–195 (1976).

    Article  PubMed  CAS  Google Scholar 

  25. Rossof, A. H., Talley, R. W., Stephens, R. L.: Phase II evaluation of single high-dose cis-diamminedichloroplatinum in gynecologic and genitourinary neoplasia. Proc. Am. Assoc. Cancer Res. 18, 97 (1977).

    Google Scholar 

  26. Samuels, M., Lancotti, V., Holoye, P., Howe, G.: Stage III testicular cancer: Complete response by substage to velban plus continuous bleomycin infusion (VB-3). Proc. Am. Assoc. Cancer Res. 18, 146 (1977).

    Google Scholar 

  27. Staubitz, W. J., Early, R., Magoss, I., Murphy, G.: Surgical management of testis tumor. J. Urol. 111, 205 (1974).

    PubMed  CAS  Google Scholar 

  28. Tyrell, C., Peckham, M.: The response of lymph node metastases of testicular teratom to radiation therapy. Br. J. Urol. 48, 363–370 (1976).

    Article  Google Scholar 

  29. Union Internationale Contre le Cancer: TNM classification of malignant tumors, 2nd ed. Geneva, 1974.

    Google Scholar 

  30. Vugrin, D., Cvitkovic, E., Whitmore, W., Golbey, R.: Prophylactic chemotherapy of testicular germ cell carcinomas (non-seminomas) Stage II following orchiectomy and retroperitoneal dissection. Proc. Am. Assoc. Cancer Res. 19, 352 (1978).

    Google Scholar 

  31. Wittes, R. E., Yagoda, A., Silvay, O., Magill, G., Whitmore, W., Krakoff, I., Golbey, R.: Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin. Cancer 37, 637–645 (1976).

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Muggia, F.M., Jacobs, E.M. (1979). Adjuvant Chemotherapy of Testicular Carcinoma: Need for Evaluation of Curative Strategies. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81332-0_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81334-4

  • Online ISBN: 978-3-642-81332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics